[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"heart-rhythm-disorders\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:heart-rhythm-disorders":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,56,94,133],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":33,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":4},"100623450","screening-for-cardiac-and-cardiac-associated-pathology-using-single-channel-electrocardiogram-100623450",false,"NCT07396792","Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram","Screening for Cardiac and Cardiac-associated Pathology Using Single-channel Electrocardiogram Analyzed With Machine Learning Models","Inclusion Criteria:\n\n1. The presence of written informed consent of the patient to participate in the study\n2. Availability of examination data allowing for the verification or exclusion of cardiac and cardiac-associated pathology\n3. Age 18 years old and older\n\nNon-inclusion criteria:\n\n1. Patients with an implanted permanent pacemaker;\n2. ECG changes that prevent spectral analysis;\n3. Conditions that may impair the quality of the ECG recording (Parkinson's disease, essential tremor, etc.);\n4. Conditions that make ECG recording in lead I impossible (congenital anomalies of the upper limbs, traumatic amputation of the upper limbs).\n5. Lack of written informed consent from the patient to participate in the study.\n\nExclusion Criteria:\n\n1. Poor quality of the ECG recording on a single-channel ECG monitor\n2. Insufficient examination data to verify or exclude cardiac or cardiac-associated pathology;\n3. Patient's unwillingness to continue participating in the study for any reason.",true,"ALL","18 Years",{"count":20,"type":21},4000,"ESTIMATED","OBSERVATIONAL","It is a prospective, controlled, single-center, observational, non-randomized study. The study is planned to include at least 4000 patients 18 years old and older in the training sample and 1000 patients over 18 years old in the test sample (the total number of patients is at least 5000 people). Patients will be included in the study if they have undergone a full examination (laboratory, clinical and instrumental), allowing for the verification or exclusion of cardiac and cardiac-associated pathology in accordance with current recommendations. During the course of the study, the authors of the work do not interfere with the above-mentioned scope of the examination, which is carried out on patients in accordance with clinical guidelines. All patients included in the study will undergo ECG recording in standard lead I for 1 minute twice, followed by spectral analysis of the obtained data, which will be stored at the remote monitoring center of Sechenov University without being linked to the personal data of patients. A spectral analysis of the electrocardiogram will be performed using a continuous wavelet transform. The result of this study will be the identification of ECG parameters that will correlate with cardiac and cardiac-associated pathology",[25,26,27,28,29,30,31,32],"Arterial Hypertension","Heart Rhythm Disorders","Valvular Heart Diseases","Heart Failure","Diabetes Mellitus","Chronic Kidney Disease (Stage 3-4)","Metabolic Syndrome","Coronary Artery Disease",[34,35,36,37,38,39,40,41,42,43],"Screening","Electrocardiogramm","single-channel electrocardiogram","machine learning models","Coronary artery disease","diabetes mellitus","metabolic syndrome","anemia","hypercholesterolemia","arterial hypertension","NOT_YET_RECRUITING","2026-04-13",{"date":47,"type":48},"2026-04-16","ACTUAL",{"date":50,"type":21},"2026-04-01",{"date":52,"type":21},"2028-05-13",{"name":54,"class":55},"I.M. Sechenov First Moscow State Medical University","OTHER",{"id":57,"slug":58,"hasResults":11,"nctId":59,"briefTitle":60,"officialTitle":61,"acronym":62,"eligibilityCriteria":63,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":64,"targetDuration":4,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":74,"overallStatus":44,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":93},"100620186","optimal-settings-for-anti-tachycardia-pacing-atp-on-icd-100620186","NCT07354347","Optimal Settings for Anti Tachycardia Pacing (ATP) on ICD","Optimal ATP Settings in the VT Zone for New Implantable Cardioverter Defibrillator (ICD) Implantation (DAN-ATP)","DAN-ATP","Inclusion Criteria:\n\n\\- ICD implantation for primary or secondary prophylactic indication\n\nExclusion Criteria:\n\n* None\n* Patients can actively opt out of participation in the study",{"count":65,"type":21},3980,"INTERVENTIONAL",[68],"NA","This is a pragmatic, two-group, cluster randomized trial designed to compare strategies for the Anti Tachycardia Pacing (ATP)-setting in the ventricular tachyarrhythmias (VT) zone when implanting a new implantable cardioverter defibrillator (ICD) in patients with heart disease in hospitals in Denmark.\n\nThe strategies are: \"Burst\" or \"Ramp\" after 1. ATP (which is always burst) in VT zone. VT zone is defined between 180-249 (up to 269 in special cases) heartbeats per minute.\n\nThe ICD will give either:\n\nBurst: The ICD is programmed to give ATP with 4 bursts. Or Ramp: The ICD is programmed to give ATP with 1 burst and 3 ramps.\n\nThe participating hospitals will be assigned to one of two intervention strategies for periods of 4-months. The given intervention will follow the patient\u002FICD throughout the life time of the ICD, but with the possibility to reprogram at any time (intention to treat).\n\nIt is calculated that the study needs a total of 398 events (second to fourth ATP), which is estimated to require 3980 implanted ICDs. The participants will be followed until the end of the ICD life, which is estimated to be around 10 years.",[71,72,26,73],"Heart Disease","Implantable Cardioverter Defibrillator (ICD)","Ventricular Tachyarrhythmias",[75,76,77,78,79,80,81,82,83],"Heart failure","ICD","ATP","Anti Takykardi Pacing","Implantable Cardioverter Defibrillator","cluster randomisation","heart rhythm disorder","ventricular tachyarrhythmias","VT","2026-01-26",{"date":86,"type":48},"2026-01-27",{"date":88,"type":21},"2026-02-01",{"date":90,"type":21},"2041-07-31",{"name":92,"class":55},"Rigshospitalet, Denmark",1,{"id":95,"slug":96,"hasResults":11,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":100,"eligibilityCriteria":101,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":102,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":104,"conditions":105,"keywords":118,"overallStatus":122,"whyStopped":4,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":132},"100358354","the-role-of-concomitant-diseases-in-postoperative-complications-risk-stratification-100358354","NCT03945968","The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.","The Role of Concomitant Diseases in Postoperative Complications Risk Stratification - a Prospective Observational Multi-center Cohort Study","STOPRISK","Inclusion Criteria:\n\n* surgical interventions on the abdominal organs,\n* 1-3 ASA physical status class\n\nExclusion Criteria:\n\n* the inability to assess the factors included in the study,\n* acute massive blood loss, aspiration,\n* bronchospasm,\n* anaphylactic reactions,\n* malignant hyperthermia",{"count":103,"type":21},16000,"Study is conducted to assess the prevalence and structure of comorbidity among patients undergoing abdominal surgery and produce the stratification of the risk of postoperative complications by identifying independent predictors for its development.",[106,107,108,109,110,111,26,112,113,114,115,116,117],"Coronary Heart Disease","Anemia","Bronchial Asthma","Stroke","Epilepsy","Parkinson's Disease","Alzheimer's Disease","Neuromuscular Diseases","Diabetes","Chronic Heart Failure","Chronic Obstructive Pulmonary Disease","Chronic Kidney Diseases",[119,120,121],"anesthesia","concomitant diseases","risk stratification","RECRUITING","2025-04-01",{"date":125,"type":48},"2025-04-04",{"date":127,"type":48},"2019-07-01",{"date":129,"type":21},"2026-02-28",{"name":131,"class":55},"Russian Federation of Anesthesiologists and Reanimatologists",38,{"id":134,"slug":135,"hasResults":11,"nctId":136,"briefTitle":137,"officialTitle":138,"acronym":139,"eligibilityCriteria":140,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":141,"targetDuration":143,"studyType":22,"phases":4,"briefSummary":144,"conditions":145,"keywords":4,"overallStatus":122,"whyStopped":4,"lastUpdateSubmitDate":147,"lastUpdatePostDateStruct":148,"startDateStruct":150,"completionDateStruct":152,"leadSponsor":154,"locationsCount":93},"100555053","dosimetric-reference-levels-for-radioguided-interventional-procedures-in-rhythmology-100555053","NCT06507085","Dosimetric Reference Levels for Radioguided Interventional Procedures in Rhythmology.","Dosimetric Reference Levels for Radioguided Interventional Procedures in Rhythmology. The NR-Rythmo Study","NR-Rythmo","Inclusion Criteria:\n\n* Adult male\u002Ffemale patient (≥ 18 years)\n* Body Mass Index (BMI) between 18 and 35 kg\u002Fm².\n* Patient to benefit from one of the following procedures:\n\nPlacement of single-chamber pacemaker with lead (DELF 007 according to CCAM) Dual-chamber pacemaker insertion with lead (DELF 005 according to CCAM) Multi-site pacemaker placement (DELF 001 and\u002For DELF 015 according to CCAM) Placement of single-chamber endovascular defibrillator (DELF 013 according to CCAM) Placement of dual-chamber endovascular defibrillator (DELF 015 according to CCAM) Placement of multi-site defibrillator (DELF 020 or DELF 014 according to CCAM) Primo Ablation Typical Atrial Flutter: Cavotricuspid Isthmus only (DEPF 012 according to CCAM) Primo Ablation tachycardia by intra nodal re-entry (DEPF 010 according to CCAM) Accessory pathway ablation (DEPF 005 according to CCAM) Paroxysmal atrial fibrillation ablation (4 pulmonary veins only, all technologies combined; DEPF 033 as per CCAM) Primo Ablation Persistent atrial fibrillation (4 pulmonary veins ± lines ± substrate; DEPF 033 ± DEPF 014 ± DENF 018 ± DEPF 012 according to CCAM)\n\nExclusion Criteria:\n\n* Patient whose procedure does not require X-rays\n* Pregnant women",{"count":142,"type":21},6600,"12 Months","Interventional radiology has become a widespread technique used in various fields of medicine to diagnose or treat numerous pathologies. However, the risk of X-rays must be taken into account. In 2019, the French Authority on Nuclear Safety published diagnostic reference levels for radio-guided interventional practices for 10 interventional radiology procedures and 2 interventional cardiology procedures, based on studies published by the French Society of Medical Physics in collaboration with the French Society of Radiology and the French Coronary Artery Disease and Interventional Cardiology Group. Reference levels for interventional procedures under CT guidance were also defined in 2020 following a national multicenter study coordinated by Nîmes University Hospital (NIMAO NRD-SI). However, no national multicentre studies have ever defined reference levels for radioguided interventional procedures in rhythmology. The aim of this study is to define standard national dosimetric levels for a number of radioguided interventional procedures in rhythmology.",[146,26],"Radiology, Interventional","2024-07-11",{"date":149,"type":48},"2024-07-18",{"date":151,"type":48},"2024-05-01",{"date":153,"type":21},"2026-01-01",{"name":155,"class":55},"Centre Hospitalier Universitaire de Nīmes"]